title: Randomized trial of spacers in asthma.
abstract: OBJECTIVE
  To compare the efficacy of all types of spacers commonly available to children in India.
  
  
  METHODS
  150 children 5-14 yr of age with persistent asthma presenting with peak expiratory flow (PEF) < 70% of personal best were randomized to receive 200 mg salbutamol through one of five spacers: A) 750 ml spacer with valve, B) 165 ml spacer with valve, C) 250 ml spacer without valve, D) 1000 ml indigenously made spacer without valve and E) 500 ml indigenously made spacer without valve. PEF measurement was repeated 15 minutes later. Children> 8 yr old performed spirometry in addition to PEF. Absolute change and percentage improvement of PEF and FEV1 were compared among the groups.
  
  
  RESULTS
  Subjects in all groups had comparable baseline demographic characteristics and PEF. All showed significant improvement in PEF and FEV1 over baseline values. The change in PEF and percentage improvement were comparable among all five groups (p=0.780 and p=0.955 respectively). Likewise change in FEV1 and percentage improvement were also comparable. The five groups showed no difference in efficacy, irrespective of severity of baseline airway obstruction.
  
  
  CONCLUSIONS
  The five spacers were equally efficacious for the delivery of bronchodilator in children with moderate persistent asthma presenting with airway obstruction.
authors: Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. meenusingh4@rediffmail.com.
authors: Baljit
authors: B
authors: Dahiya
authors: Joseph L
authors: JL
authors: Mathew
authors: Meenu
authors: M
authors: Singh
mesh_terms: D000293:Adolescent; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage*; D000420:Albuterol / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D036503:Inhalation Spacers; D008297:Male; D036501:Metered Dose Inhalers; D010366:Peak Expiratory Flow Rate
chemical_list: D000316:Adrenergic alpha-Agonists; D001993:Bronchodilator Agents; D000420:Albuterol
references: Respir Med. 2003 Jan;97(1):86-9
references: 12556017
references: Lancet. 1999 Sep 18;354(9183):979-82
references: 10501359
references: Pediatr Pulmonol. 1997 Sep;24(3):204-12
references: 9330417
references: Indian Pediatr. 1977 Aug;14(8):591-4
references: 591015
references: Arch Dis Child. 2000 Jun;82(6):495-8
references: 10833188
references: Ann Trop Paediatr. 1998 Jun;18(2):75-9
references: 9924566
references: Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
references: 7663792
references: Thorax. 1993 Jun;48(6):603-6
references: 8346488
references: Indian J Pediatr. 2001 Jan;68(1):37-40
references: 11237234
references: Am Rev Respir Dis. 1981 Sep;124(3):317-20
references: 7283266
references: Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005536
references: 18425921
references: Cochrane Database Syst Rev. 2003;(3):CD000052
references: 12917881
references: Pediatr Allergy Immunol. 2002 Jun;13(3):217-22
references: 12144645
references: J Am Acad Nurse Pract. 2002 Sep;14(9):390-7
references: 12375358
references: Br J Clin Pharmacol. 1995 Jul;40(1):76-8
references: 8527272
references: J Pediatr. 2004 Aug;145(2):172-7
references: 15289762
references: J Assoc Physicians India. 2002 Mar;50:397-9
references: 11922231